跳至主要内容
临床试验/CTRI/2022/07/043987
CTRI/2022/07/043987已完成不适用

A Randomized Clinical Trial on the Role of Shigru Taila Nasya and Gaganesvara Rasa with or without Haritakyadi Churna Virechana in Vataja Pratishyaya with special reference To Allergic Rhinitis.

National institute Of Ayurveda Deemed To Be University Jaipur1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年8月12日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Change in visual analogues scale.

研究概览

简要总结

The increasing prevalence of Allergic Rhinitis has affected global health problem effecting a quarter of the world population. Over 400 million people suffer from Allergic Rhinitis around the world and to a large extent it remains under diagnosed and under treated. About 20-30% of  Indian population  suffer from  at least  one  allergic  disease where allergic rhinitis alone constitutes about 55% of all allergies.

Allergic Rhinitis symptoms result in sleep disturbances, fatigue, depressed mood and cognitive functions which impairs quality of life and productivity. Many treatment modalities are explained in Allopathic science like corticosteroids, anti allergic drugs, inhalers, antihistamines etc. but none of them are totally effective in curing the disease as well as preventing its recurrence, more over they have their own side effects. Although innumerable preparations are available in modern science, no drug ensures complete relief without any side effects and the chances of recurrences are relatively high. Hence there is a need for more effective, safe, treatment modality which is especially beneficial in chronic cases to treat this problem from grass root level.

Kostha suddhi is very beneficial for removing the Doshas from the body especially in chronic cases as the Doshas are lodged in different parts of body. Sarvanga Abhyanga and Sweda**nahelp in diverting the Doshas from Shakhas toKoshta which can then can be expelled through Haritakyadi Churna Virechana. Moreover, in Vataja Pratishyaya, as there is Vimarga gamana of Vata Dosha, Virechana does Shareera shodhana and Vata Anulomana and hence it can be beneficial in this disease. Along with that, Nasya Karma is considered as the main Shodhana therapy to expel Doshas from the Shiras.  Hence Shigru Taila Nasya has been selected which is considered as a drug of choice in Vataja Pratishyaya. In order to promote Shamana effect, Gaganesvara rasa is selected for internal administration in patients suffering from Vataja Pratishyaya (Allergic Rhinitis). Hence this study entitled,A Randomized clinicalTrial on the Role of Shigru Taila Nasya and Gaganesvara  Rasa with or without Haritakyadi  churna  Virechana in Vataja Pratishyaya with special reference To  Allergic Rhinitis is selected for providing a better relief without any recurrence in order to find an effective solution to the above problem for curing the disease from its root cause.

Aim and Objectives

Aim

To evaluate the efficacy of Shigru Taila Nasya, Gaganesvara Rasa with and without Haritakyadi Churna Virechana in  Vataja Pratishyaya with special reference to Allergic Rhinitis

Objectives

·         To evaluate the efficacy of Shigru Taila Nasya and Gaganesvara Rasa orally with Haritakyadi Churna Virechana  in Vataja Pratishyaya with special reference to Allergic Rhinitis.

·         To evaluate the efficacy of Shigru Taila Nasya and Gaganesvara Rasa orally without Haritakyadi Churna Virechana in Vataja Pratishyaya with special reference to Allergic Rhinitis

Study Medication**:**

Group A - 15 patients of Vataja Pratishyaya will be given Haritakyadi Churna Virechana followed by Shigru Taila Nasya along with internal administration of Gaganesvara Rasa.

Group B – 15 patients of Vataja Pratishyaya will be given Shigru Taila Nasya and internal administration of Gaganesvara Rasa.

·

·       Treatment Plan :

 Treatment

Duration

Follow up

|Group- 1

Koshta Shuddi-

Sarvanga Abhyanga and Swedana for one day followed by 6 to 10 gms of Haritakyadi Churna  Virechana  given with luke warm water

Marsha Nasya with Shigru Taila in dosage of 6 drops each nostril

  3 to 7 days as per Koshta shuddhi

  14 days (2 sittings each of 7 days with an interval of 7 days in between).

       Once in 15 days

2 follow ups after treatment

Gaganesvara Rasa 250 mg b.d. with honey

21 days Starting along with Nasya karma

  |Group- 2

Marsha Nasya with Shigru Taila indosageof 6 drops in each nostril.

14 days (2 sittings each of 7 days with an interval of 7 days in between).

Gaganesvara Rasa 250 mg b.d. with honey

21 days, starting along with Marsha Nasya.

 Â·         Assessment Criteria: -

To assess the relief  in signs and symptoms mentioned below, a specific scoring pattern  will be adopted.

a. ShirohShoola /Shirogaurava (Headache)

b. Tanusravapravartan (Rhinorrhoea)

c. Kshavathu (Sneezing)

d. Aanaddha Nasa (Nasal obstruction)

e. Swaropaghata  (Hoarseness of voice)

f. Kasa (Cough)

g. Kandu (Itching)

h. Nasal Congestion.

i. Turbinate hypertrophy

 â—       Laboratory Investigations –

Following investigations will be carried out before and after trial.

1.      Absolute Eosinophil Count(AEC)

2.      CBC

3.      ESR

4.      Allergen- specific Ig E Antibody Test.

Hypothesis:-

Null Hypothesis- H0

There is no difference in the effect ofShigru Taila Nasya, Gaganesvara  Rasa with or without Haritakyadi Churna Virechana in Vataja Pratishyaya with special referenceTo Allergic Rhinitis.

Alternate Hypothesis-

There is difference in the effect ofShigru Taila Nasya, Gaganesvara  Rasa with or without Haritakyadi Churna Virechana  in  Vataja Pratishyaya with Special reference To Allergic Rhinitis.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • (1) Patients willing to participate in the study (2) Patients between the age group of 18– 60 yrs.
  • (3) Patients presenting with signs and symptoms of Vataja Pratishyaya mentioned in Ayurvedic Classics and Allergic Rhinitis according to Allopathic science.

排除标准

  • 1.Patients having history of systemic disease as Diabetes Mellitus, Hypertension, Hypothyroidism.
  • 2.Patients suffering from gross deviation of nasal septum, nasal tumours, adenoid hyperplasia, nasal polyps etc.
  • 3.Pregnant women.
  • 4.Patients not fit for Nasya therapy and Virechana.

结局指标

主要结局

Change in visual analogues scale.

时间窗: 30 days

次要结局

  • Change in nasal congestion and turbinate hypertrophy.(30 days)

研究者

发起方
National institute Of Ayurveda Deemed To Be University Jaipur
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验